Literature DB >> 23210715

Quantum dots: heralding a brighter future for clinical diagnostics.

Tamer M Samir1, Mai M H Mansour, Steven C Kazmierczak, Hassan M E Azzazy.   

Abstract

Quantum dots (QDs) are semiconductor nanocrystals that possess unique optical properties including broad-range excitation, size-tunable narrow emission spectra and high photostability, giving them considerable value in various biomedical applications. The size and composition of QDs can be varied to obtain the desired emission properties and make them amenable to simultaneous detection of multiple targets. Furthermore, numerous surface functionalizations can be used to adapt QDs to the needed application. The successful use of QDs has been reported in the areas of in vitro diagnostics and imaging. There is also potential for multimodal applications for simultaneous imaging. Toxicity issues are still a prime concern with regards to in vivo applications on account of the toxic constituents of QDs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23210715     DOI: 10.2217/nnm.12.147

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  5 in total

Review 1.  Evaluation of optical detection platforms for multiplexed detection of proteins and the need for point-of-care biosensors for clinical use.

Authors:  Samantha Spindel; Kim E Sapsford
Journal:  Sensors (Basel)       Date:  2014-11-25       Impact factor: 3.576

2.  Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics.

Authors:  Gan Lin; Peng Mi; Chengchao Chu; Jun Zhang; Gang Liu
Journal:  Adv Sci (Weinh)       Date:  2016-05-30       Impact factor: 16.806

Review 3.  Quantum Dots as Multifunctional Materials for Tumor Imaging and Therapy.

Authors:  Longfei Liu; Qingqing Miao; Gaolin Liang
Journal:  Materials (Basel)       Date:  2013-02-05       Impact factor: 3.623

4.  Quantum-dot-based suspension microarray for multiplex detection of lung cancer markers: preclinical validation and comparison with the Luminex xMAP® system.

Authors:  Regina Bilan; Amagoia Ametzazurra; Kristina Brazhnik; Sergio Escorza; David Fernández; María Uríbarri; Igor Nabiev; Alyona Sukhanova
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

5.  Quantum dot/pMHC multimers vs. phycoerythrin/pMHC tetramers for identification of HLA-A*0201-restricted pHBV core antigen18-27-specific T cells.

Authors:  Jianmeng Zhu; Yong Huang; Jing Su; Jian He; Yating Yu; Yongxiang Zhao; Xiaoling Lu
Journal:  Mol Med Rep       Date:  2017-08-01       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.